C170 (Darifenacin Hydrobromide Extended-Release 7.5 mg (base))
Pill with imprint C170 is Yellow, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg (base). It is supplied by Par Pharmaceutical, Inc..
Darifenacin is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for C170
Darifenacin Hydrobromide Extended-Release
- Imprint:
- C170
- Strength:
- 7.5 mg (base)
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Par Pharmaceutical, Inc.
- National Drug Code (NDC):
- 10370-0170
More about darifenacin
- Darifenacin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 20 Reviews
- Drug class: urinary antispasmodics
Consumer resources
Other brands: Enablex
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
